Shuxu Yang Selected Research

Shuxu Yang Research Topics

Disease

8	Glioma (Gliomas) 04/2016 - 10/2012
7	Neoplasms (Cancer) 01/2022 - 11/2012
4	Cerebral Hemorrhage 01/2021 - 12/2006
4	Brain Injuries (Brain Injury) 03/2020 - 12/2006
4	Glioblastoma (Glioblastoma Multiforme) 02/2020 - 01/2015
3	Brain Edema (Cerebral Edema) 01/2021 - 12/2006
2	Chronic Subdural Hematoma 05/2021 - 03/2020
2	Subdural Effusion (Subdural Hygroma) 04/2021 - 01/2016
2	Traumatic Brain Injuries (Traumatic Brain Injury) 04/2018 - 01/2016
1	Pancreatitis 10/2021
1	Epilepsy (Aura) 05/2021
1	Acute Subdural Hematoma 05/2021
1	Aphasia (Dysphasia) 05/2021
1	Inflammation (Inflammations) 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Cryptococcal Meningitis 10/2020
1	Intracranial Hypertension 10/2020
1	Hemorrhage 03/2020
1	Pneumonia (Pneumonitis) 04/2018
1	Carcinoma (Carcinomatosis) 07/2017
1	Tuberculosis (Tuberculoses) 11/2016
1	Blister (Bulla) 04/2016
1	Wounds and Injuries (Trauma) 09/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2015
1	Cysts 11/2013
1	Depressed Skull Fracture 01/2013
1	Meningioma (Meningiomas) 06/2010
1	Edema (Dropsy) 06/2010
1	Atrophy 03/2009
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2005

Drug/Important Bio-Agent (IBA)

4	MicroRNAs (MicroRNA)IBA 01/2015 - 10/2012
3	Temozolomide (Temodar)FDA LinkGeneric 12/2016 - 01/2015
3	beta CateninIBA 08/2015 - 06/2010
2	DNA (Deoxyribonucleic Acid)IBA 11/2016 - 09/2015
2	CateninsIBA 04/2016 - 06/2010
2	CytokinesIBA 10/2012 - 03/2009
2	Thrombin FDA Link 03/2009 - 07/2008
1	AlbuminsIBA 01/2022
1	Ferritins (Ferritin)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Silk FDA Link 01/2022
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	HMGB1 Protein (HMG1)IBA 01/2021
1	Triggering Receptor Expressed on Myeloid Cells-1IBA 01/2021
1	Protein Kinase CIBA 01/2021
1	Glycyrrhizic Acid (Glycyrrhizin)IBA 01/2021
1	Amphotericin B (Amphotericin)FDA LinkGeneric 10/2020
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 03/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2020
1	AcidsIBA 11/2016
1	norcantharidinIBA 04/2016
1	Cantharidin (Cantharides)IBA 04/2016
1	Pharmaceutical PreparationsIBA 04/2016
1	astaxanthine (astaxanthin)IBA 09/2015
1	Neuroprotective AgentsIBA 09/2015
1	MethyltransferasesIBA 09/2015
1	RNA (Ribonucleic Acid)IBA 09/2015
1	ElementsIBA 09/2015
1	Antineoplastic Agents (Antineoplastics)IBA 08/2015
1	ParaffinIBA 07/2013
1	Phosphotransferases (Kinase)IBA 05/2013
1	TitaniumIBA 01/2013
1	Therapeutic UsesIBA 11/2012
1	Antisense OligonucleotidesIBA 11/2012
1	Bcl-2-Like Protein 11IBA 11/2012
1	Cytokine Receptors (Cytokine Receptor)IBA 10/2012
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2012
1	Nerve Growth Factors (Neurotrophins)IBA 10/2012
1	Cadherins (E-Cadherin)IBA 06/2010
1	Interleukin-1beta (Interleukin 1 beta)IBA 03/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2009
1	Minocycline (Cyclops)FDA LinkGeneric 03/2009
1	Complement C5 (Complement 5)IBA 12/2006
1	Heme (Haem)IBA 12/2006
1	Complement System Proteins (Complement)IBA 12/2006
1	Complement C3 (C3 Complement)IBA 12/2006
1	salicylhydroxamic acid (SHAM)IBA 04/2005

Therapy/Procedure

5	Therapeutics 01/2022 - 07/2013
2	Craniotomy 05/2021 - 03/2020
2	Operative Surgical Procedures 05/2021 - 01/2016
2	Drug Therapy (Chemotherapy) 12/2016 - 09/2015
1	Precision Medicine 01/2022
1	Decompressive Craniectomy 04/2021
1	Intranasal Administration 01/2021
1	Length of Stay 04/2018
1	Artificial Respiration (Mechanical Ventilation) 04/2018
1	Tracheostomy 04/2018
1	Nanospheres 07/2017
1	Microspheres (Microsphere) 06/2017
1	Conservative Treatment 01/2016
1	Punctures 11/2013